You are here

Press Releases

Press Release | October 8, 2014
FOR IMMEDIATE RELEASE                                                        Oct. 8, 2014 AdvaMed Honors Medtronic Co-Founder Earl Bakken with Lifetime Achievement Award    Chicago, Ill. – The Advanced Medical Technology Association (AdvaMed) today... Read More
Press Release | October 6, 2014
FOR IMMEDIATE RELEASE                                                                                   Oct. 6, 2014 Study Shows Insurers Tightening Coverage Evidence Requirements, Adopting New Provider Payment Models Analysis Shows Need for... Read More
Statement | September 30, 2014
Context of Payments is Critical When Reviewing Data WASHINGTON, D.C. – Christopher White, senior executive vice president and general counsel for the Advanced Medical Technology Association (AdvaMed), issued the following statement today on the... Read More
Statement | September 30, 2014
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, released the following statement regarding the release of draft guidance by FDA on the regulation of laboratory-developed tests (LDTs): “AdvaMedDx appreciates FDA’s release of draft... Read More
Press Release | September 19, 2014
HOUSE VOTES FOR REPEAL OF DEVICE TAX Washington, D.C. – The Medical Imaging & Technology Alliance (MITA), Advanced Medical Technology Association (AdvaMed) and the Medical Device Manufacturers Association (MDMA) today announced their collective... Read More
Press Release | September 18, 2014
Nanjing, China – Christopher L. White, senior executive vice president and general counsel for the Advanced Medical Technology Association (AdvaMed), today issued the following statement in response to an Asia-Pacific Economic Cooperation (APEC)... Read More
Press Release | September 16, 2014
  WASHINGTON, D.C. – Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on the release of an omnibus jobs bill (H.R. 4) in the U.S. House of Representatives which includes... Read More
Press Release | September 9, 2014
Risk-based Approach Will Support Innovation, Patient Safety WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, testified before the U.S. House of Representatives Energy and Commerce Committee today in support of FDA taking a risk-based... Read More
Press Release | August 21, 2014
Auburn, NY (August 21, 2014) – Leaders of New York’s bioscience and medical technology (Bio/Med) industry joined U.S. Rep. Dan Maffei (D-NY) today to address how companies within the sector can drive the state’s economic competitiveness and future... Read More
Statement | July 31, 2014
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, released the following statement regarding FDA’s congressional notification and draft framework on the regulation of laboratory-developed tests (LDTs): “AdvaMedDx welcomes the... Read More

Pages